A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Reference |
|---|
| "The metabolic syndrome is characterized by atherogenic dyslipidemia (elevated triglycerides, increased small dense low-density lipoproteins, and decreased high-density lipoproteins), hypertension, insulin resistance and obesity." | ( Fenselau, S; Schrezenmeir, J; Steinmetz, A, 2001) |
| "Metabolic syndrome is associated with increased cardiovascular risk." | ( Idzior-Waluś, B, 2001) |
| "Metabolic syndrome is characterized by a clustering of metabolic abnormalities: insulin resistance - hyperinsulinemia, dyslipidemia (high triglycerides and low HDL - cholesterol serum concentrations), impaired glucose tolerance and/or type 2 diabetes, and hypertension." | ( Bueno, M; Fleta, J; Giner, A; Juste, MG; Moreno, LA; Pineda, I; Rodríguez, G; Sarría, A, 2002) |
| "Metabolic syndrome is more prevalent in men than in women." | ( Busserolles, J; Gueux, E; Mazur, A; Rayssiguier, Y; Rock, E, 2002) |
| "The metabolic syndrome is characterized by insulin resistance and abnormal apolipoprotein AI (apoAI) and apolipoprotein B-100 (apoB) metabolism that may collectively accelerate atherosclerosis." | ( Barrett, PH; Chan, DC; Croft, KD; Ji, J; Johnson, AG; Loehrer, F; Serone, AP; Watts, GF, 2003) |
| "The metabolic syndrome is characterized by defective hepatic apolipoprotein B-100 (apoB) metabolism." | ( Barrett, PH; Chan, DC; O'Neill, FH; Thompson, GR; Watts, GF, 2003) |
| "It appears that the metabolic syndrome is associated with risk that is not entirely accounted for by traditional risk scoring paradigms." | ( Beere, PA; Clearfield, M; Girman, CJ; Gotto, AM; Kjekshus, J; Mercuri, M; Pedersen, TR; Pyörälä, K; Rhodes, T, 2004) |
| "The metabolic syndrome is a highly prevalent condition that affects 24% of American adults and significantly increases the risk of coronary heart disease (CHD)." | ( Ito, MK, 2004) |
| "Treatment of the metabolic syndrome is recommended by NCEP-ATP III to further reduce CHD risk after the LDL-C target has been met." | ( Ito, MK, 2004) |
| "The multiple metabolic syndrome is defined by a clustering of risk factors for cardiovascular disease." | ( Klein, BE; Klein, R; Lee, KE, 2003) |
| "The metabolic syndrome is associated with increased morbility and mortality for cardiovascular disease." | ( Avogaro, A, 2003) |
| "Metabolic syndrome is defined as a clustering of cardiovascular risk factors (abdominal obesity, hyperinsulinemia, atherogenic dyslipidemia, hypertension and hypercoagulability) that together increase the risk of developing coronary heart disease and type 2 diabetes." | ( Harwood, HJ, 2004) |
| "Metabolic syndrome is characterized by insulin resistance (IR) as well as dyslipidemia, ventral overweight, hypertension and elevated fasting plasma glucose." | ( Belowski, D; Kalina, M; Kalina, Z; Kochanski, L; Okopien, B; Wysocki, J, 2004) |
| "The cardiovascular metabolic syndrome is characterized by the presence of several cardiovascular risk factors, including blood pressure (BP) elevation." | ( Eide, I; Fossum, E; Høieggen, A; Kjeldsen, SE; Moan, A; Reims, HM; Rostrup, M, 2004) |
| "The metabolic syndrome is associated with a high risk of cardiovascular disease morbidity and mortality." | ( Baik, HW; Kim, WY; Oh, SW; Park, HS; Yoon, YS, 2004) |
| "The metabolic syndrome is commonly encountered in the United States." | ( Reasner, CA; Rosenson, RS, 2004) |
| "Early diagnosis of metabolic syndrome is based on detection of insulin resistance, hyperinsulinemia, and clinical presentations of this syndrome." | ( Dorosh, ZhV; Roĭtberg, GE; Ushakova, TI, 2004) |
| "The metabolic syndrome is a highly complex breakdown of normal physiology characterized by obesity, insulin resistance, hyperlipidemia, and hypertension." | ( Csete, M; Doyle, J; Kimura, T; Kitano, H; Matsuoka, Y; Muramatsu, M; Oda, K, 2004) |
| "The metabolic syndrome is characterized by an excess of intra-abdominal fat, hypoadiponectinemia, insulin resistance in skeletal muscle and adipose tissue, multiple defects in glucose and energy metabolism, and elevated levels of cytokines and adhesion molecules." | ( Kainulainen, S; Laakso, M; Pihlajamäki, J; Punnonen, K; Ruotsalainen, E; Salmenniemi, U; Vanninen, E; Vauhkonen, I, 2004) |
| "The metabolic syndrome is associated with activation of the renin-angiotensin system." | ( Araiza, A; Dincer, UD; Knudson, JD; Kuo, L; Setty, S; Tune, JD; Zhang, C, 2005) |
| "The metabolic syndrome is associated with increased angiotensin II activity, induction of a proinflammatory and oxidative state, and endothelial dysfunction." | ( Cheema, FA; Khan, BV; Khan-Merchant, N; Menon, RG; Mir, MQ; Parthasarathy, S; Sola, S, 2005) |
| "Metabolic syndrome is a common disorder in Taiwan." | ( Chiou, WK; Fang, JT; Lin, JD; Liu, TH; Ou, YC; Weng, HF, 2005) |
| "Metabolic syndrome is associated with subclinical organ damage in nondiabetic, essential hypertensive patients." | ( Deferrari, G; Falqui, V; Leoncini, G; Parodi, A; Parodi, D; Pontremoli, R; Ratto, E; Tomolillo, C; Vaccaro, V; Viazzi, F, 2005) |
| "The metabolic syndrome is a high-risk state for diabetes and cardiovascular disease." | ( Fowler, S; Goldberg, R; Haffner, S; Marcovina, S; Orchard, TJ; Ratner, R; Temprosa, M, 2005) |
| "Both diabetes and metabolic syndrome are associated with a clustering of cardiovascular risk factors." | ( Betteridge, J; Shepherd, J; Van Gaal, L, 2005) |
| "Metabolic syndrome is a cardiovascular risk factors cluster and hyperhomocysteinemia an obvious independant risk factor." | ( Abouzahir, A; Baigts, F; Bauduceau, B; Bordier, L; Burnat, P; Dupuy, O; Garcin, JM; Gardet, V; Mayaudon, H, 2005) |
| "The metabolic syndrome is strongly associated with insulin resistance and has been recognized as a cluster of risk factors for cardiovascular diseases such as visceral obesity, hypertension, diabetes and dyslipidemia." | ( Imaizumi, T; Jinnouchi, Y; Nakamura, K; Takenaka, K; Yamagishi, S, 2005) |
| "The metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that raise the risk for cardiovascular diseases and diabetes mellitus." | ( Matsui, T; Sato, T; Takeuchi, M; Yamagishi, S, 2006) |
| "The metabolic syndrome is accompanied by an elevated level of serum insulin, which is known to enhance the synthesis of saturated and monounsaturated fatty acids, such as 16:0 and 18:1, and to stimulate the activity delta-6 desaturase, decreasing the concentration of linoleic acid." | ( Alho, H; Kunnas, T; Leskinen, MH; Nikkari, ST; Solakivi, T, 2005) |
| "Although metabolic syndrome is associated with inflammation in the general population, it is unknown whether similar associations exist in patients with chronic kidney disease." | ( Beddhu, S; Cheung, AK; Kimmel, PL; Ramkumar, N, 2005) |
| "Metabolic syndrome is associated with inflammation in patients with varying levels of kidney function." | ( Beddhu, S; Cheung, AK; Kimmel, PL; Ramkumar, N, 2005) |
| "The metabolic syndrome is associated with a high incidence of cardiovascular disease even when the abnormalities present in the syndrome are mild." | ( Adachi, H; Enomoto, M; Furuki, K; Hino, A; Hirai, Y; Hiratsuka, A; Imaizumi, T; Satoh, A; Takeuchi, T; Tsuruta, M, 2005) |
| "Metabolic syndrome is a cluster of metabolic abnormalities, including hypertension, hyperlipidemia, hyperinsulinemia, glucose intolerance and obesity." | ( Kagota, S; Kobayashi, K; Kubota, Y; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tanaka, N; Yamaguchi, Y, 2006) |
| "The metabolic syndrome is a complex multifactorial disease, which results from interactions between genes on multiple chromosomes and environmental factors." | ( Charchar, FJ; Dominiczak, AF; Graham, D; McBride, MW; Sattar, N; Strahorn, P, 2005) |
| "Metabolic syndrome is a constellation of clinical findings that identify individuals at higher than normal risk of developing diabetes mellitus or cardiovascular disease." | ( Citrome, L, 2005) |
| "The metabolic syndrome is defined as the clustering of cardiovascular risk factors, such as glucose intolerance, hyperinsulinemia, dyslipidemia, coagulation disturbances and hypertension." | ( Chinetti-Gbaguidi, G; Fruchart, JC; Staels, B, 2005) |
| "Metabolic syndrome is associated with an increased progression of aortic stiffness with age, supporting premature senescence in these patients." | ( Benetos, A; Blacher, J; Bureau, JM; Nzietchueng, R; Pannier, B; Safar, ME; Thomas, F, 2006) |
| "The metabolic syndrome is a constellation of risk factors that contribute to the onset of type 2 diabetes mellitus and cardiovascular disease (CVD)." | ( Nesto, RW, 2005) |
| "The Metabolic syndrome is a widely prevalent and multi-factorial disorder." | ( Agarwal, PK; Gogia, A, 2006) |
| "The metabolic syndrome is characterized by the clustering of insulin resistance, dyslipidemia, and hypertension and is associated with increased risk of cardiovascular disease and type 2 diabetes mellitus." | ( Kurtz, TW, 2006) |
| "Metabolic syndrome is a group of metabolic abnormalities associated with increased cardiovascular and mortality risks." | ( Wang, M, 2006) |
| "The metabolic syndrome is present in about half of individuals with symptomatic intracranial atherosclerotic disease and is associated with a substantially higher risk of major vascular events." | ( Chimowitz, M; Lynn, MJ; Ovbiagele, B; Saver, JL, 2006) |
| "The metabolic syndrome is considered a state of chronic inflammation accompanied of endothelial dysfunction causing an increased incidence of ischemic cardiovascular events and high mortality." | ( Bahia, L; Bottino, D; Bouskela, E; de Aguiar, LG; Villela, NR, 2006) |
| "Patients with metabolic syndrome are older (44." | ( de Villar, NG; Estrada, V; Fernández, C; González-Sánchez, JL; Martínez-Larrad, MT; Serrano-Ríos, M; Zabena, C, 2006) |
| "Metabolic syndrome is a cluster of metabolic diseases that in essence greatly promotes progression of atherosclerosis." | ( Haginaka, J; Kagota, S; Kunitomo, M; Nakamura, K; Yamaguchi, Y; Yoshikawa, N, 2006) |
| "The metabolic syndrome is a clustering of risk factors including central obesity, insulin resistance, dyslipidaemia and hypertension." | ( Athyros, VG; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP, 2006) |
| "Metabolic syndrome is one of the major causes of morbidity and mortality in the world." | ( Chakrabarti, CS; Das, M; Majumder, PP; Mukhopadhyay, B; Sarkar, S, 2006) |
| "The metabolic syndrome is associated with increased cardiovascular risk." | ( Hajer, GR; Olijhoek, JK; van der Graaf, Y; Verhaar, MC; Visseren, FL, 2007) |
| "Metabolic syndrome is > or =3 of the following: hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hypertension, abdominal obesity, and high serum glucose." | ( Gorbach, SL; Jacobson, DL; Skinner, S; Spiegelman, D; Tang, AM; Thomas, AM; Wanke, C, 2006) |
| "Metabolic syndrome is mostly diagnosed through low HDL and high triglycerides in HIV." | ( Gorbach, SL; Jacobson, DL; Skinner, S; Spiegelman, D; Tang, AM; Thomas, AM; Wanke, C, 2006) |
| "Metabolic syndrome is a global epidemic problem." | ( Bogdański, P; Chyrek, R; Jabłecka, A; Pupek-Musialik, D, 2006) |
| "Metabolic syndrome is associated with increased inflammatory process." | ( Bogdański, P; Chyrek, R; Jabłecka, A; Pupek-Musialik, D, 2006) |
| "Metabolic syndrome is an important risk factor for proteinuria and chronic kidney disease independent of diabetes and hypertension; however, the underlying mechanisms have not been elucidated." | ( Ando, K; Fujita, T; Gotoda, T; Nagase, M; Nagase, T; Shibata, S; Yoshida, S, 2006) |
| "Metabolic syndrome is associated with a pro-inflammatory state, and the role of visceral obesity is thought to be central to this." | ( Connell, JM; Ritchie, SA, 2007) |
| "The metabolic syndrome is also a cluster of abnormalities with basic characteristics being insulin resistance and visceral obesity." | ( Katsilambros, N; Liatis, S; Tentolouris, N, 2006) |
| "The metabolic syndrome is a common risk factor for cardiovascular and chronic kidney disease (CKD) in Western populations." | ( Batuman, V; Chen, CS; Chen, J; Gu, D; Hamm, LL; He, J; Lee, CH; Muntner, P; Whelton, PK; Wu, X, 2007) |
| "Metabolic syndrome is common and it is associated with increased cardiovascular mortality." | ( Katsilambros, N; Liatis, S; Moyssakis, I; Papazafiropoulou, A; Perrea, D; Soldatos, RP; Tentolouris, N, 2007) |
| "The metabolic syndrome is a group of risk factors of metabolic origin that are accompanied by increased risk for type 2 diabetes mellitus and cardiovascular disease." | ( Carruba, MO; Clementi, E; Moncada, S; Nisoli, E, 2007) |
| "The metabolic syndrome is a cluster of common pathologies: abdominal obesity linked to an excess of visceral fat, insulin resistance, dyslipidemia and hypertension." | ( Gueux, E; Mazur, A; Nowacki, W; Rayssiguier, Y; Rock, E, 2006) |
| "The metabolic syndrome is a cluster of cardiovascular risk factors leading to an increased risk for the subsequent development of diabetes and cardiovascular morbidity and mortality." | ( Bramlage, P; Kintscher, U; Paar, WD; Thoenes, M; Unger, T, 2007) |
| "The metabolic syndrome is an insulin-resistant state that is characterized by a cluster of cardiovascular risk factors, including abdominal obesity, hyperglycemia, elevated blood pressure and combined dyslipidemia." | ( Cariou, B; Staels, B, 2007) |
| "The metabolic syndrome is associated with increased cholesterol synthesis and reduced cholesterol absorption in a relationship that is graded across severity of the individual components of the syndrome and across an index of the severity of the metabolic syndrome as a whole." | ( Assmann, G; Cullen, P; Kannenberg, F; Schulte, H, 2007) |
| "The metabolic syndrome is associated with an increased risk for coronary heart disease." | ( Frauendorf, T; Grisk, O; Klöting, I; Krebs, A; Kuttler, B; Lüdemann, J; Rettig, R; Schlüter, T, 2007) |
| "Metabolic syndrome is characterized by obesity, elevated blood pressure (BP), insulin resistance, and hypercholesterolemia." | ( Akil, H; Britton, SL; Buck, BJ; Burghardt, PR; Kerman, IA; Koch, LG; Watson, SJ, 2007) |
| "The metabolic syndrome is a crucial factor in causation of type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) in South Asians." | ( Banerjee, D; Misra, A; Misra, R; Wijesuriya, M, 2007) |
| "Metabolic syndrome is associated with adverse cardiovascular outcome, independently of its associations with diabetes and obesity." | ( Bertrand, M; Daly, CA; Ferrari, R; Fox, KM; Hildebrandt, P; Remme, W; Simoons, M, 2007) |
| "Metabolic syndrome is a group of factors which increase the risk for development of diabetes, cardiovascular diseases and includes insulin resistance, abdominal adiposity, hyperlipidemia, hypertension and other disorders." | ( Avdagić, N; Fajkić, A; Lepara, O; Nakag-Ićindić, E; Valjevac, A, 2007) |
| "Patients with metabolic syndrome are at increased risk for cardiovascular complications." | ( Abdel-Latif, A; AlMahameed, A; Bhatt, DL; Blankenship, JC; Brennan, D; Chew, DP; Corbelli, JC; Eres, A; Gilchrist, IC; Grines, C; Hazen, SL; Leesar, M; McErlean, E; Mukherjee, D; Resar, JR; Steinhubl, S; Tan, WA; Tang, HW; Tang, WH; Topol, EJ, 2007) |
| "The metabolic syndrome is a long-term process, explained by the interaction of genetic and environmental factors, that starts early in life and is involved in the pathophysiology of a large percentage of cases with type 2 diabetes and atherosclerosis." | ( Calabria, M; Capoccia, D; Iannucci, CV; Leonetti, F, 2007) |
| "The metabolic syndrome is an emerging global epidemic characterized by clustering of metabolic abnormalities leading to increased cardiovascular risk: glucose intolerance or type 2 diabetes, dyslipidemia, hypertension, and "central" obesity." | ( Lo Sasso, G; Moschetta, A; Palasciano, G; Petruzzelli, M; Portincasa, P, 2007) |
| "The metabolic syndrome is common in patients receiving lipid-lowering therapy in an office-based setting." | ( Ballantyne, CM; Davidson, MH; Deedwania, PC; Dicklin, MR; Maki, KC; Stone, NJ, 2006) |
| "The metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that raise the risk for cardiovascular diseases and diabetes mellitus." | ( Matsui, T; Nakamura, K; Yamagishi, S, 2007) |
| "Metabolic syndrome is a clinical disorder that is becoming more prevalent in Spain." | ( Aguilar, MV; Arrieta, FJ; González, MJ; Martínez-Para, MC; Mateos, CJ; Meseguer, I; Saavedra, P, 2007) |
| "Obesity and the metabolic syndrome are becoming one of the biggest health challenges of the 21(st) century." | ( Atherton, JJ; Hoenig, MR; Kostner, KM; Read, SJ; Walker, PJ, 2007) |
| "The metabolic syndrome is a risk factor for the development of renal and vascular complications." | ( Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N, 2007) |
| "Metabolic syndrome is a strong determinant of new-onset diabetes and coronary heart disease in general populations." | ( Carson, WH; Casey, DE; Kan, HJ; L'Italien, GJ; Marcus, RN, 2007) |
| "Metabolic syndrome is characterized by a group of risk factors for cardiovascular diseases, such as abdominal obesity, low high-density lipoprotein (HDL) cholesterol, elevated triglycerides, elevated arterial blood pressure, insulin resistance or impaired glucose tolerance." | ( Jelski, W; Szmitkowski, M, 2007) |
| "Metabolic syndrome is characterized by the variable coexistence of obesity, hyperinsulinemia, insulin resistance, dyslipidemia, and hypertension." | ( Alenina, N; Alvarez-Leite, JI; Bader, M; Botion, LM; Fernandes, LR; Ferreira, AV; Mario, EG; Pôrto, LC; Santos, RA; Santos, SH, 2008) |
| "The metabolic syndrome is defined as a clustering of cardiovascular risk factors with insulin resistance, including dyslipidemia, coagulation disturbances and hypertension." | ( Chinetti-Gbaguidi, G; Staels, B, 2007) |
| "Metabolic syndrome is characterized by insulin insensitivity, central obesity dyslipidemia, and hypertension." | ( Spark, RF, 2007) |
| "The metabolic syndrome is a group of disorders including obesity, insulin resistance, atherogenic dyslipidemia, hyperglycemia, and hypertension." | ( Fordstrom, P; Helmering, J; Kaufman, SA; Kim, KW; Lindberg, RA; Lloyd, DJ; McCormick, J; Véniant, MM; Wang, M, 2008) |
| "As the metabolic syndrome is an important side effect of some antipsychotics, use of a biomarker will enable clinicians to identify metabolic changes more effectively than anthropometry and biochemistry." | ( Bai, YM; Chen, JY; Chi, YC; Chou, P; Lin, CC; Lin, CY; Liou, YJ; Su, TP; Wang, YC; Yang, WS, 2007) |
| "The metabolic syndrome is a cluster of metabolic disorders, such as abdominal obesity, dyslipidemia, hypertension and impaired fasting glucose that contribute to increased cardiovascular morbidity and mortality." | ( Nagao, K; Yanagita, T, 2008) |
| "The prevalence of metabolic syndrome is high and is increasing in parallel with increasing incidences of breast and prostate cancers." | ( Li, L; Pan, W; Zhou, JR, 2007) |
| "The metabolic syndrome is a constellation of interrelated metabolic risk factors that appear to promote the development of diabetes and cardiovascular disease." | ( Schnackenberg, CG, 2008) |
| "Recently, metabolic syndrome is increasing in Japan and it is thought to be the cause of coronary heart disease." | ( Ikeda, S; Koga, S; Kohno, S; Yamasa, T, 2008) |
| "Although metabolic syndrome is generally associated with type 2 diabetes mellitus, the present review emphasizes the possible presence of metabolic syndrome in type 1 diabetes and the impact of insulin resistance on micro- and macrovascular complications." | ( Chillarón, JJ; Goday, A; Pedro-Botet, J, 2008) |
| "Metabolic syndrome is a cluster of cardiovascular risk factors such as hypertriglyceridemia, hypertension, insulin resistance, based on visceral fat accumulation." | ( Tomita, K; Yamasaki, T, 2008) |
| "Metabolic syndrome is an aggregation of hypertension, diabetes and dyslipidaemia." | ( Fujita, T, 2008) |
| "The prevalence of metabolic syndrome is increasing globally and is an important risk factor for the development of cardiovascular disease." | ( Jones, TH; Kapoor, D, 2008) |
| "Metabolic syndrome is prevalently associated with stroke." | ( Fujioka, D; Kawabata, K; Kobayashi, T; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Sano, K; Takano, H; Yano, T, 2009) |
| "The metabolic syndrome is a constellation of risk factors including glucose dysregulation, central obesity, dyslipidemia, and hypertension." | ( Gallagher, E; Lann, D; Leroith, D, 2008) |
| "Obesity and metabolic syndrome are significant problems for patients taking antipsychotic drugs." | ( Cooper, SJ; Doherty, JK; O'Neill, R; Reynolds, GP; Woodside, JV; Yevtushenko, OO, 2008) |
| "The metabolic syndrome is well recognized in adults, and there is convincing evidence that it starts in childhood, with progressive clustering of the various components over time and tracking through adulthood." | ( Arslanian, S; Tfayli, H, 2008) |
| "The metabolic syndrome is a cluster of cardiovascular risk factors and essential components of metabolic syndrome are hyperglycemia, hypertension, visceral obesity, hypertriglyceridemia and low high-density lipoprotein cholesterol." | ( Armutcu, F; Ataymen, M; Atmaca, H; Gurel, A, 2008) |
| "Metabolic syndrome is a highly predisposing condition for cardiovascular disease and could be a cause of excess salt-induced organ damage." | ( Ando, K; Fujita, M; Fujita, T; Kawarazaki, H; Matsui, H; Nagae, A; Nagase, M; Shimosawa, T, 2008) |
| "When the metabolic syndrome is present, insulin resistance and hyperinsulinemia may contribute to hypertension through diverse mechanisms." | ( Setaro, JF; Singer, GM, 2008) |
| "The metabolic syndrome is a risk factor for the development of chronic kidney disease." | ( Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N, 2008) |
| "The metabolic syndrome is a common and complex disorder combining obesity, dyslipidemia, hypertension, and insulin resistance." | ( Holvoet, P, 2008) |
| "Metabolic syndrome is considered as clustering of cardiovascular risk factors related to insulin resistance." | ( Kushiro, T; Takahashi, A, 2008) |
| "Metabolic syndrome is associated with an increased incidence of atherosclerosis." | ( Bi, XP; Gong, HP; Li, L; Tan, HW; Xing, SS; Zhang, W; Zhang, Y; Zhong, M, 2008) |
| "The metabolic syndrome is associated with lower-than-normal testosterone levels." | ( Gooren, LJ; Saad, F; Yassin, AA, 2008) |
| "Both OSAS and metabolic syndrome are strongly associated with obesity." | ( Koike, H; Matsui, H; Sando, Y; Tokuda, F; Yokoyama, T, 2008) |
| "These mechanisms in metabolic syndrome are risk factors towards atherosclerosis and cancer diseases as well." | ( Halmos, T; Suba, I, 2008) |
| "The metabolic syndrome is a widely prevalent constellation of risk factors for cardiovascular disease." | ( Halvorsen, LK; Tonstad, S, 2008) |
| "Metabolic syndrome is currently the research topic of several studies." | ( Manjunatha, N; Saddichha, S, 2009) |
| "The metabolic syndrome is associated with an overactivity of the autonomic nervous system." | ( Gooren, LJ; Haider, A; Padungtod, P; Saad, F, 2009) |
| "The subjects with metabolic syndrome are an increased risk for the development of diabetes mellitus and cardiovascular disease as well as an increased mortality for cardiovascular disease in all causes." | ( Agoşton-Coldea, L; Albu, A; Mocan, T; Pais, R; Perna, S; Rusu, LD; Rusu, ML, 2008) |
| "The metabolic syndrome is considered to be an important public health problem." | ( Bauduceau, B; Burnat, P; Ceppa, F; Mayaudon, H; Merens, A, 2008) |
| "Metabolic syndrome is prevalent in older adults and increases the risk of cardiovascular disease." | ( Brooks, JO; Chang, HS; Krasnykh, O, 2009) |
| "The metabolic syndrome is a risk factor for mortality, over and above the Framingham risk score, in middle-aged, but not in elderly individuals." | ( Dahl, AA; Hildrum, B; Midthjell, K; Mykletun, A, 2009) |
| "Obesity and metabolic syndrome are associated with low serum testosterone levels." | ( Aumann, N; Krebs, A; Lerch, MM; Nauck, M; Rosskopf, D; Steveling, A; Völzke, H; Wallaschofski, H, 2010) |
| "The metabolic syndrome is a clustering of risk factors known to promote or increase the risk of diabetes development and subsequent cardiovascular disease." | ( Malik, S; Wong, ND, 2009) |
| "The metabolic syndrome is a highly complex disease and has become one of the major public-health challenges worldwide." | ( Bailey-Wilson, JE; Cheng, CY; Duggal, P; Klein, BE; Klein, R; Lee, KE; Moore, EL; Wilson, AF, 2010) |
| "The metabolic syndrome is a clustering of risk factors predisposing to late onset diabetes mellitus, atherosclerosis and cardiovascular morbidity and mortality." | ( Gooren, L; Saad, F, 2009) |
| "Metabolic syndrome is a cluster of some of the most dangerous cardiovascular risk factors, and its high prevalence in people with mental illness has been demonstrated." | ( Brunero, S; Fairbrother, G; Lamont, S, 2009) |
| "Metabolic syndrome is associated with higher cardiovascular morbidity and mortality." | ( Bouskela, E; Kraemer-Aguiar, LG; Lima, LM; Wiernsperger, N, 2009) |
| "Metabolic syndrome is associated with increased risk for type 2 diabetes and cardiovascular disease." | ( Lau, DC, 2009) |
| "Metabolic syndrome is associated with an increased risk of diabetes and cardiovascular disease." | ( Chang, JH; Chang, TI; Choi, HY; Han, DS; Kang, SW; Kim, DK; Kim, E; Kim, HW; Lee, JE; Park, JT; Park, SY; Yoo, TH, 2009) |
| "Patients with the metabolic syndrome are at an increased risk of cardiovascular disease and might require intensive lipid therapy." | ( Adewale, AJ; Ballantyne, CM; Grundy, SM; Hsueh, WA; Parving, HH; Polis, AB; Robinson, JG; Rosen, JB; Tershakovec, AM; Tomassini, JE, 2009) |
| "The metabolic syndrome is a condition frequently found among individuals > 60 years of age." | ( Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H, 2009) |
| "The coexisting metabolic syndrome is associated with an increase in the levels of some systemic inflammatory markers and physical inactivity, independent of lung function impairment." | ( Holz, O; Kirsten, A; Kretschmar, G; Magnussen, H; Meyer, T; Müller, KC; Waschki, B; Watz, H, 2009) |
| "Likewise, the metabolic syndrome is a secondary target of treatment." | ( Thompson, PD, 2003) |
| "Incidence of the metabolic syndrome is increasing worldwide, with notable exceptions of some Asian countries where seaweeds are commonly consumed." | ( Baldeón, ME; Braverman, LE; Chiriboga, DE; Davis, JR; Sarriés, AJ; Teas, J, 2009) |
| "Metabolic syndrome is a chronic low-grade inflammatory condition in which adipokines play a major role." | ( Damato, AB; Depalo, R; Garruti, G; Giampetruzzi, F; Giorgino, F; Lorusso, F; Vita, MG, 2009) |
| "Metabolic syndrome is a risk factor for prolonged QTc, which may further increase cardiovascular morbidity and mortality in the subjects with metabolic syndrome." | ( Bai, Y; Fan, X; Han, Y; Hui, R; Li, W; Song, H; Song, X; Sun, K; Wang, Y; Xue, H, 2009) |
| "Metabolic syndrome is associated with intravascular inflammation, as determined by increased levels of inflammatory biomarkers and an increased risk of ischemic atherothrombotic events." | ( Cable, G; Willerson, JT; Yeh, ET, 2009) |
| "Metabolic syndrome is characterized by central obesity, dyslipidemia, hypertension, and insulin resistance." | ( Miyagawa, Y; Okuyama, A; Takao, T; Tsujimura, A, 2010) |
| "The metabolic syndrome is a clustering of risk factors predisposing to diabetes mellitus type 2, atherosclerosis and cardiovascular morbidity and mortality." | ( Saad, F, 2009) |
| "Metabolic syndrome is ascribed to lipotoxicity caused by age-related resistance to antilipotoxic protection by leptin." | ( Scherer, PE; Unger, RH, 2010) |
| "The metabolic syndrome is prevalent and has become an important financial burden to the healthcare system in both developed and developing countries." | ( Brown, L; Iyer, A; Panchal, S; Poudyal, H, 2009) |
| "Obesity and metabolic syndrome are common among Roma subjects in Slovakia." | ( Dorkova, Z; Sopkova, Z; Tkacova, R, 2010) |
| "The metabolic syndrome is a cluster of common pathologies, including abdominal obesity linked to an excess of visceral fat, fatty liver, insulin resistance, hyperinsulinemia, dyslipidemia, and hypertension." | ( Ferder, L; Ferder, MD; Inserra, F, 2010) |
| "The metabolic syndrome is a cluster of symptoms that function as risk factors for cardiovascular disease (CVD), and its key components--diabetes, dyslipidemia, and hypertension--form a lethal combination." | ( Mehta, A, 2010) |
| "The concept that metabolic syndrome is an inflammatory condition may explain the role of Mg." | ( Libako, P; Nowacki, W; Rayssiguier, Y; Rock, E, 2010) |
| "The metabolic syndrome is a risk factor that increases the risk for development of renal and vascular complications." | ( Aldini, G; Braidotti, P; Carini, M; Negrisoli, G; Orioli, M; Rossoni, G; Savi, F; Vistoli, G; Yeum, KJ, 2011) |
| "Patients with the metabolic syndrome are at increased cardiovascular risk and display an augmented wall stiffness of the large-sized and medium-sized arteries, coupled with an endothelial dysfunction." | ( Bolla, G; Brambilla, G; Facchetti, R; Grassi, G; Mancia, G; Mozzi, E; Seravalle, G, 2010) |
| "Thus, metabolic syndrome is characterized by marked alterations in the structural and functional patterns of the small resistance arteries." | ( Bolla, G; Brambilla, G; Facchetti, R; Grassi, G; Mancia, G; Mozzi, E; Seravalle, G, 2010) |
| "The metabolic syndrome is an increasing etiology of HCC and carcinogenesis in this context may not always require the development of formal underlying cirrhosis." | ( Barbare, JC; Belghiti, J; Castaing, D; Chirica, M; Farges, O; Paradis, V; Soubrane, O; Vullierme, MP, 2010) |
| "1." | ( Fukushima, K; Kagota, S; Kunitomo, M; Mori, H; Nakamura, K; Nejime, N; Shinozuka, K; Sugimura, K; Tada, Y; Umetani, K, 2010) |
| "Metabolic syndrome is a group of disorders involving obesity, insulin resistance, dyslipidemia and hypertension." | ( Cai, G; Freeland-Graves, JH; Jordan, KC; Klohe, DM; Lane, MA; Voruganti, VS, 2010) |
| "The Metabolic Syndrome is a diagnosis of increasing prevalence that is noted to share multiple clinical features with Cushing's syndrome." | ( Khan, M; Krikorian, A, 2010) |
| "Obesity and the metabolic syndrome are rapidly increasing in developing countries." | ( Bhushan, B; Guleria, R; Misra, A, 2010) |
| "Metabolic syndrome is an independent predictor for NODAT and is a possible target for intervention to prevent NODAT." | ( Anil Kumar, MS; Bayer, ND; Bloom, RD; Cochetti, PT; Doria, C; Huan, Y; Rosas, SE; Teal, V, 2010) |
| "The metabolic syndrome is associated with increased risk for development of both cardiovascular disease and type 2 diabetes in humans." | ( Beaudeux, JL; Giral, P; Nivet-Antoine, V, 2010) |
| "Metabolic syndrome is marked by perturbed glucocorticoid (GC) signaling, systemic inflammation, and altered immune status." | ( Ahlem, CN; Auci, DL; Frincke, JM; Kennedy, MR; Page, TM; Reading, CL, 2011) |
| "The metabolic syndrome is a clustering of risk factors of metabolic origin that increase the risk for cardiovascular disease and type 2 diabetes." | ( Borniquel, S; Carlström, M; Hezel, M; Larsen, FJ; Lundberg, JO; Nyström, T; Weitzberg, E, 2010) |
| "The metabolic syndrome is associated with male hypogonadism, but specific studies about the mechanisms and treatment of the testosterone deficit are scanty." | ( Caldas, AD; Casulari, LA; Domingues Casulari Motta, L; Lofrano-Porto, A, 2010) |
| "In fact, the metabolic syndrome is a strong predictor of NAFLD." | ( Yoshida, M, 2011) |
| "Metabolic syndrome is a risk factor for nephrolithiasis." | ( De Filippo, G; Mossetti, G; Muscariello, R; Rendina, D; Strazzullo, P; Zampa, G, 2011) |
| "Metabolic Syndrome is associated with increased risk for type 2 diabetes and cardiovascular diseases." | ( Bulgiba, A; Moy, FM, 2010) |
| "Metabolic syndrome is common in this Malay cohort regardless of the criterion used." | ( Bulgiba, A; Moy, FM, 2010) |
| "Patients with metabolic syndrome are at increased risk of atherosclerotic coronary heart disease, often have mixed dyslipidemia, and may thus require more aggressive treatment of multiple lipid parameters." | ( Bays, HE; Gumbiner, B; Macdonell, G; Shah, A; Taggart, WV, 2011) |
| "The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism." | ( Butcher, JT; Frisbee, JC; Goodwill, AG; Olfert, IM, 2011) |
| "The metabolic syndrome is characterized by clustering of risk factors, which predisposes subjects to increased risk of diabetes and cardiovascular disease." | ( Gupte, MD; Kaur, P; Radhakrishnan, E; Rao, SR; Rao, TV; Sankarasubbaiyan, S, 2010) |
| "Thus, metabolic syndrome is a low-grade systemic inflammatory condition and could be due to inappropriate cross-talk between the peripheral tissues and the hypothalamic centers implying that methods designed to restore these two abnormalities to normal could be of significant benefit in metabolic syndrome." | ( Das, UN, 2011) |
| "Metabolic syndrome is common in patients with hypertension and increases the risk of developing diabetes mellitus." | ( Comi-Diaz, C; Macias-Batista, A; Martinez-Martin, FJ; Pedrianes-Martin, P; Rodriguez-Rosas, H; Soriano-Perera, P, 2011) |
| "Metabolic syndrome is an important side effect associated with clozapine." | ( Bai, YM; Chen, JY; Chen, TT; Chou, P; Lin, CC; Su, TP, 2011) |
| "Metabolic syndrome is a disease that today affects millions of people around the world." | ( Botezelli, JD; Cambri, LT; Ghezzi, AC; Mello, MA; Ribeiro, C, 2011) |
| "Prevalence of metabolic syndrome is high among Asians including Indians." | ( Deshmukh, PR; Garg, N; Kamble, P, 2010) |
| "Metabolic syndrome is a proatherosclerotic condition clustering cardiovascular risk factors, including glucose and lipid profile alterations." | ( Bergamini, E; Bertolotto, M; Dallegri, F; Delrio, A; Franciosi, U; Lenglet, S; Mach, F; Minetti, S; Montecucco, F; Ottonello, L; Pelli, G; Pende, A; Puddu, A; Quercioli, A; Viviani, GL; Vuilleumier, N, 2011) |
| "Metabolic syndrome is a cluster of risk factors including insulin resistance and type 2 diabetes and is found to associate partly with chronic stress at work in human." | ( Hori, M; Kanemoto, S; Kiyotani, Y; Maehara, H; Nagasaka, R; Ohara, K; Uchida, A; Ushio, H, 2011) |
| "Metabolic syndrome is defined by a cluster of cardiovascular disease risk factors that are associated with insulin resistance." | ( Power, M; Pratley, R, 2011) |
| "Metabolic syndrome is secondary to obesity and characterized by dyslipidemia, insulin resistance, and hypertension." | ( Allers, C; Conget, P; Ezquer, F; Ezquer, M; Ricca, M, 2011) |
| "Metabolic syndrome is a powerful predictor of cardiovascular events independent of overt diabetes." | ( Cater, G; Devendra, GP; Krasuski, RA; Whitney, EJ, 2011) |
| "The metabolic syndrome is characterized by the accumulation of several metabolic risk factors." | ( Guo, W; Itoh, N; Kawano, H; Node, K; Piao, L; Sato, T, 2011) |
| "A case of metabolic syndrome is reported in which its elimination before the onset of antiviral treatment of chronic hepatitis A and drug therapy of subsequent depression promoted successful outcome with a stable virological response." | ( Baĭzhanova, ZhZh; Ignatova, TM; Kinkul'kina, MA, 2010) |
| "The metabolic syndrome is defined as a cluster of disorders including visceral obesity, insulin resistance, hypertension, hypertriglyceridemia and low HDL." | ( Bauer, S; Buechler, C, 2012) |
| "The metabolic syndrome is a complex condition characterized by obesity, insulin resistance, decreased high-density lipoproteins, and hypertension associated with high risk of developing type 2 diabetes and cardiovascular disease." | ( Dahlman-Wright, K; Faulds, MH; Gustafsson, JÅ; Zhao, C, 2012) |
| "Metabolic syndrome is associated with pro-inflammatory and prothrombotic state." | ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "The metabolic syndrome is an emerging clinical problem and different kinds of interventions have emphasized that healthy eating and exercise are crucial to its control." | ( Carnier, J; Corrêa, FA; Dâmaso, AR; de Mello, MT; de Piano, A; Ernandes, RM; Sanches, Pde L; Tock, L; Tufik, S, 2011) |
| "The metabolic syndrome is an obesity-associated disease manifested as severe insulin resistance, hyperlipidemia, hepatic steatosis, and diabetes." | ( Habener, JF; Stanojevic, V; Tomas, E; Wood, JA, 2011) |
| "As metabolic syndrome is associated with higher serum alkaline phosphatase levels, we examined the joint association of mortality with metabolic syndrome and serum alkaline phosphatase levels in the US general population." | ( Baird, BC; Beddhu, S; Greene, T; Krishnamurthy, VR; Raphael, K; Wei, G, 2011) |
| "Metabolic syndrome is known to facilitate the development of cardiovascular disease." | ( Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y, 2011) |
| "Obesity and the metabolic syndrome are closely related and have become increasingly prevalent in Korea." | ( Blumenthal, JA; Georgiades, A; Lee, SY; Park, SB, 2011) |
| "Metabolic syndrome is defined as a set of health risk factors that are associated with an increased chance of cardiovascular diseases and type 2 diabetes." | ( Brown, L; Weng-Yew, W, 2011) |
| "The metabolic syndrome is common in populations exposed to a typical Western diet." | ( Bauer, CA; Cavazos, NE; Comuzzie, AG; Dick, EJ; Garcia-Forey, M; Hemmat, P; Higgins, PB; Mubiru, JN; Owston, MA; Rogers, J; Shade, RE, 2011) |
| "The metabolic syndrome is an important cluster of coronary heart disease risk factors with common insulin resistance." | ( Krishnan, A; Misra, P; Sinha, S; Upadhyay, RP; Vikram, NK, 2011) |
| "Metabolic syndrome is associated with muscle weakness, and this relationship is particularly pronounced in men." | ( Jang, HC; Kim, KW; Lim, JY; Lim, S; Paik, NJ; Yang, EJ, 2012) |
| "The metabolic syndrome is a cluster of common pathologies: abdominal obesity linked to an excess of visceral fat, insulin resistance, dyslipidemia and hypertension." | ( Farooqui, AA; Farooqui, T; Frisardi, V; Panza, F, 2012) |
| "Metabolic syndrome is a combination of medical disorders that increases the risk of developing cardiovascular disease and diabetes." | ( Alonso-Galicia, M; Daugherty, BL; Gao, L; Hernandez, M; Li, XQ; Lisnock, J; Mundt, SS; O'Neill, EA; Puig, O; Springer, MS; Zhang, L; Zhou, Y; Zhu, AY, 2012) |
| "Metabolic syndrome is associated with an increased risk of major cardiovascular events." | ( Abe, M; Kawamoto, R; Kohara, K; Kusunoki, T; Miki, T; Tabara, Y, 2012) |
| "Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events." | ( Colman, PG; Davis, TM; Donoghoe, M; Fulcher, G; Keech, AC; Manning, P; O'Brien, R; Pardy, C; Scott, R; Taskinen, MR; Watts, GF, 2011) |
| "The metabolic syndrome is a group of abnormalities including obesity, high blood pressure, hyperinsulinemia, high blood glucose levels and hyperlipidemia that together greatly increase the risk of developing cardiovascular disease and Type 2 diabetes." | ( Chang, T; Desai, KM; Untereiner, A; Wu, L, 2011) |
| "Metabolic syndrome is a low-grade inflammatory state in which oxidative stress is involved." | ( Chen, J; Gao, DM; Jiang, H; Mohamed, S; Pu, P; Xie, J; Zhang, J; Zhou, NJ; Zhou, XY, 2012) |
| "Metabolic syndrome is characterized by abdominal obesity, insulin resistance, dyslipidemia, and hypertension." | ( Beauwens, R; Bolaky, N; Carpentier, YA; Delforge, V; Delporte, C; Gaspard, N; Hupkens, E; Louchami, K; Malaisse, WJ; Perret, J; Portois, L; Sener, A; Zhang, Y, 2012) |
| "Obesity and metabolic syndrome are major health problems worldwide, including Turkey." | ( Abanonu, GB; Tarcin, O; Yazici, D, 2012) |
| "The Metabolic Syndrome is prevalent among cardiovascular disease patients attending the Korle Bu Teaching Hospital, with a significant association between the number of components of the Metabolic Syndrome present and the probability of developing a cardiovascular disease." | ( Akpalu, A; Akpalu, J; Ofei, F, 2011) |
| "The metabolic syndrome is associated with abnormal glucose and lipid metabolism, insulin resistance, increased oxidative stress and pro-inflammatory activity that increase the risk of type 2 diabetes and cardiovascular disease." | ( Berry, EA; De Jong, SA; Manning, PJ; Ryalls, AR; Sutherland, WH; Walker, RJ; Williams, SM, 2013) |
| "The metabolic syndrome is associated with increased risk for both diabetes and coronary artery disease, which insulin resistance alone does not satisfactorily explain." | ( Jaimungal, S; Nayak, S; Pinto Pereira, L; Seemungal, T; Teelucksingh, S, 2012) |
| "Metabolic syndrome is a risk factor for cardiovascular disease and nonalcoholic fatty liver disease (NAFLD)." | ( Brown, L; Panchal, SK; Poudyal, H, 2012) |
| "Individuals with metabolic syndrome are at high risk of developing chronic kidney disease (CKD) through unclear pathogenic mechanisms." | ( Burling, K; Campbell, M; Cava, F; Izquierdo, A; Martínez-García, C; Medina-Gomez, G; Oresic, M; Ros, M; Velagapudi, V; Velasco, I; Vidal-Puig, A; Vivas, Y, 2012) |
| "Subjects with the metabolic syndrome are significantly more likely to have higher BMI (> 25 kg/m(2)), HbA(1c) [≥ 42 mmol/mol (6." | ( Azwany, YN; Bebakar, WM; Ismail, AA; Ismail, IS; Kamaruddin, NA; Kamarul Imran, M; Khalid, BA; Khir, AS; Md Isa, SH; Mustafa, N; Nazaimoon, WM; Osman, A; Yeow, TP, 2012) |
| "The metabolic syndrome is a global health problem and is associated with subsequent development of cardiovascular disease (CVD)." | ( Bergström, GM; Schmidt, C, 2012) |
| "Metabolic syndrome is characterized by insulin resistance, which is closely related to GLUT4 content in insulin-sensitive tissues." | ( Leguisamo, NM; Lehnen, AM; Machado, UF; Markoski, MM; Okamoto, MM; Pinto, GH; Schaan, BD, 2012) |
| "Obesity and metabolic syndrome are associated with mitochondrial dysfunction and deranged regulation of metabolic genes." | ( Bassel-Duby, R; Carrer, M; Frisard, MI; Grueter, CE; Hulver, MW; Liu, N; Olson, EN; Williams, AH, 2012) |
| "Obesity and metabolic syndrome are frequently associated with elevated levels of aldosterone." | ( Adamcova, K; Chalupova, L; Zakovska, A, 2013) |
| "Metabolic syndrome is associated with a significantly increased risk of uric acid calculi development, especially those with impaired fasting glucose and hypertriglyceridemia." | ( Cho, ST; Jung, SI; Kim, TH; Myung, SC, 2013) |
| "The prevalence of metabolic syndrome is increasing disproportionately among the different ethnicities in Asia compared to the rest of the world." | ( Arif, MT; Bulgiba, A; Guallar, E; Mahadeva, S; Mohamed, R; Rahmat, R; Rampal, L; Rampal, S, 2012) |
| "Metabolic syndrome is a complex collection of interrelated conditions." | ( Chen, G; Wu, Q; Wu, WM; You, L; Zhang, TP; Zhao, YP; Zhou, L, 2012) |
| "Metabolic syndrome is a clustering of cardiovascular risk factors." | ( Kant, S; Krishnan, A; Misra, P; Nongkynrih, B; Sinha, S; Vikram, NK, 2013) |
| "Metabolic syndrome is a condition that typically includes central obesity, insulin resistance, glucose intolerance, dyslipidemia, and hypertension." | ( Cassano, AE; Karatsoreos, IN; Penraat, KA; Rasmussen, S; White, JR; Wilson, CD, 2012) |
| "Metabolic syndrome is a growing health problem worldwide." | ( Barbosa, MT; Capellini, V; Chini, EN; Escande, C; Gomes, AP; Nin, V; O'Neil, L; Price, NL; Sinclair, DA; White, TA, 2013) |
| "Metabolic syndrome is characterized by the cluster of a number of metabolic abnormalities in the presence of underlying insulin resistance." | ( Asano, T; Imae, M; Murakami, S, 2014) |
| "Metabolic syndrome is a risk factor for acute and chronic cerebrovascular diseases." | ( Antonova, KV; Lagoda, OV; Tanashian, MM, 2012) |
| "Metabolic syndrome is a multiplex disorder and puts patients on the road to type 2 diabetes and atherosclerotic cardiovascular diseases." | ( Cheng, ML; Fan, CM; Hong, CY; Huang, CF; Shiao, MS, 2013) |
| "Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease." | ( Gibson, GR; Juric, A; Tzortzis, G; Vulevic, J, 2013) |
| "The seriousness of metabolic syndrome is not due to the disease itself but its promotion of other diseases, such as erectile dysfunction and cardiovascular and cerebrovascular diseases." | ( Huh, JS; Kim, SD; Kim, SW; Kim, YJ; Sohn, DW, 2013) |
| "Metabolic syndrome is known to increase the risk of abnormal cardiac structure and function, which are considered to contribute to increased incidence of cardiovascular disease and mortality." | ( Kagota, S; Kunitomo, M; Maruyama, K; Nakamura, K; Shinozuka, K; Tada, Y; Wakuda, H, 2013) |
| "Metabolic syndrome is often beneficial from testosterone replacement therapy." | ( Gao, Y; Hu, Y; Huang, X; Liao, M; Lu, Z; Mo, L; Mo, Z; Tan, A; Wu, C; Yang, X; Zhang, H; Zhang, J; Zhang, Y, 2013) |
| "Development of metabolic syndrome is associated with impaired cardiac performance, mitochondrial dysfunction and pro-inflammatory cytokine increase, such as the macrophage migration inhibitory factor MIF." | ( Ballot, C; Decoster, B; Hassoun, SM; Lancel, S; Marciniak, C; Marechal, X; Montaigne, D; Neviere, R; Palud, A, 2013) |
| "On the other hand, metabolic syndrome is common among LT recipients before and after transplantation." | ( Alvares-da-Silva, MR; Oliveira, CP; Stefano, JT, 2013) |
| "Obesity and metabolic syndrome are associated with systemic inflammation and increased perinatal morbidity." | ( Chatterjee, PK; Desai, N; Gupta, M; Metz, CN; Rochelson, B; Roman, A; Tam Tam, H; Xue, X, 2013) |
| "Metabolic syndrome is a highly prevalent health problem within the adult population in developing countries." | ( Chu, AH; Moy, FM, 2014) |
| "Obesity and metabolic syndrome are one of the most devastating risk factors for cardiovascular diseases." | ( Dong, M; Ren, J, 2014) |
| "Metabolic syndrome is common in urban Indian overweight and obese adolescents." | ( Garg, MK; Marwaha, RK; Singh, Y; Tandon, N, 2013) |
| "The metabolic syndrome is a precursor for coronary heart disease." | ( Almeida, M; Bellehsen, M; Friedberg, JP; Kaplan, E; Suchday, S, 2014) |
| "Metabolic syndrome is a risk factor for coronary heart diseases as well as diabetes, fatty liver and several cancers." | ( Abo-Elmatty, DM; Ghattas, MH; Mehanna, ET; Mesbah, NM, 2013) |
| "Metabolic syndrome is growing in importance with the rising levels of obesity, type 2 diabetes, and insulin resistance." | ( Andersén, H; Bohlooly-Y, M; Cottrell, EC; DeSchoolmeester, J; Harno, E; Keevil, BG; Leighton, B; Turnbull, AV; White, A, 2013) |
| "Metabolic syndrome is implicated in the decline of cognitive ability." | ( Hashimoto, M; Hossain, S; Inoue, T; Katakura, M; Shido, O; Tanabe, Y; Tsuchikura, S, 2013) |
| "People with metabolic syndrome are more likely to experience cognitive decline." | ( Bilski, A; Chen, TY; Cheng, A; Cooper, B; Ferruzzi, MG; Freire, D; Gong, B; Ho, L; Janle, EM; Nguyen, T; Pasinetti, GM; Roman, J; Simon, JE; Song, BJ; Talcott, ST; Tang, C; Varghese, M; Wang, J; Wu, Q, 2013) |
| "As metabolic syndrome is considered a modifiable risk factor of breast tumorigenesis, further studies are required to assess whether inositol combined with alpha lipoic acid can be administered as a dietary supplement in breast cancer primary prevention." | ( Botti, G; Brillante, G; Capasso, I; Cavalcanti, E; Ciliberto, G; Crispo, A; D'Aiuto, G; D'Aiuto, M; De Laurentiis, M; Esposito, E; Esposito, G; Frasci, G; Fucito, A; Grimaldi, M; Maurea, N; Montella, M, 2013) |
| "Metabolic syndrome is becoming a common disease due to a rise in obesity rates among adults." | ( Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D, 2013) |
| "Metabolic syndrome is prevalent in the Asian population, but little is known about its associations with sources or types of dietary carbohydrates." | ( Lee, JE; Paik, HY; Song, S; Song, WO; Song, Y, 2014) |
| "The metabolic syndrome is featured by enhanced low-grade systemic inflammation and oxidative stress." | ( Bakker, SJ; Deetman, PE; Dullaart, RP, 2013) |
| "Metabolic syndrome is a major risk factor for cardiovascular diseases, which are still the major cause of death in developed countries." | ( Eichholzer, M; Linseisen, J; Richard, A; Rohrmann, S; Struja, T, 2014) |
| "Metabolic syndrome is common in Asian Indian patients with psoriatic arthritis, especially in those with long-standing psoriasis and active joint disease." | ( Dogra, S; Gopalakrishnan, D; Kumar, R; Sharma, A; Vijayvergiya, R, 2013) |
| "Metabolic syndrome is generally characterized by several metabolic and cardiovascular features, including obesity, insulin resistance and hypertension, all of which are known to cause renal impairment." | ( Kasahara, M; Kuwabara, T; Mori, K; Mukoyama, M; Nakagawa, T; Ueshima, K; Yasuno, S; Yokoi, H, 2014) |
| "Metabolic syndrome is a multifactorial process induced by a combination of genetic and environmental factors and recent evidence has highlighted that circadian disruption and sleep loss contribute to disease pathogenesis." | ( Bass, J; Hong, HK; Maury, E, 2014) |
| "Metabolic syndrome is associated with alterations in the structure of the gut microbiota leading to low-grade inflammatory responses." | ( Aumueller, E; Brath, H; Haslberger, AG; Hippe, B; Jahn, D; Remely, M, 2014) |
| "Metabolic syndrome is an important risk factor for cardiovascular disease (CVD)." | ( Ferns, GA; Ghayour-Mobarhan, M; Kermany, T; Salehi, M; Tavalaee, S; Zilaee, M, 2014) |
| "Metabolic syndrome is a cluster of metabolic abnormalities that identifies people at risk of diabetes and cardiovascular disease, whereas non-alcoholic fatty liver disease (NAFLD) is defined as a disorder with excess fat in the liver due to non-alcoholic causes." | ( Yki-Järvinen, H, 2014) |
| "After menopause, metabolic syndrome is more prevalent than in premenopausal women, and may plays an important role in the occurrence of myocardial infarction and other atherosclerotic and cardiovascular morbidities." | ( Meirelles, RM, 2014) |
| "Metabolic syndrome is associated with both schizophrenia and antipsychotic medication, especially clozapine, with alterations in inflammatory cytokines and adipokines." | ( Hämäläinen, M; Kampman, O; Klemettilä, JP; Leinonen, E; Moilanen, E; Seppälä, N; Viikki, M, 2014) |
| "Obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (CV) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations." | ( Babcák, M; Babinská, I; Cecetková, B; Drazilová, S; Fedacko, J; Gecková, AM; Janicko, M; Jankajová, M; Jarcuska, P; Kalanin, P; Kmec, J; Mareková, M; Pazinka, P; Pella, D; Pella, J; Sabol, F; Siegfried, L; Veselíny, E, 2014) |
| "The metabolic syndrome is associated with an increased risk of development and progression of chronic kidney disease." | ( Jiang, J; Li, Y; Lin, X; Liu, C; Wang, J; Yamahara, J; Yang, M; Zuo, G, 2014) |
| "The prevalence of metabolic syndrome is high among urban young adults in India, and it increased with increase in body mass index (BMI)." | ( Allam, RR; Chava, N; Kattula, SR; Manjunath, D; Oruganti, G; Uthappa, CK, 2014) |
| "The occurrence of metabolic syndrome is more common in patients with psoriasis in comparison to the general population." | ( Kacalak-Rzepka, A; Kiedrowicz, M; Maleszka, R, 2013) |
| "Metabolic syndrome is an important risk factor for cardiovascular disease (CVD) occurrence and mortality." | ( Hosseinzadeh, H; Razavi, BM, 2014) |
| "The metabolic syndrome is a worldwide problem mainly caused by obesity." | ( Eberhard, D; Fischer, J; Ikels, K; Kaisers, W; Kuschel, S; Rüther, U, 2014) |
| "Metabolic syndrome is increasingly recognized for its effects on cognitive health." | ( Ramagiri, S; Sharma, S; Taliyan, R, 2015) |
| "Obesity and metabolic syndrome is prevalent among Malaysian adolescents and has been associated with certain behavioural factors such as duration of sleep, screen time and physical activity." | ( Al Sadat, N; Cantwell, MM; Fadzlina, AA; Harun, F; Jalaludin, MY; Majid, HA; Murray, L; Nurul Haniza, MY; Su, TT, 2014) |
| "Metabolic syndrome is characterized by the association of 3 or more risk factors, including: abdominal obesity associated with an excess of abdominal fat, insulin resistance, type 2 diabetes, dyslipidemia and hypertension." | ( Bernardes, N; Brito, Jde O; Conti, FF; De Angelis, K; Dias, Dda S; Irigoyen, MC; Llesuy, SF; Malfitano, C; Sanches, IC, 2014) |
| "Metabolic syndrome is extremely prevalent in the world and can be considered as one of main factors leading to accelerated aging and premature death." | ( Rzheshevsky, AV, 2014) |
| "Metabolic syndrome is a set of mutually associated factors including insulin resistance, hyperinsulinemia, obesity, lipids disorders and hypertension, which is the main cause of development of coronary heart disease and type 2 diabetes." | ( Koter-Michalak, M; Maćczak, A; Pytel, E; Sicińska, P, 2015) |
| "Diabetes and metabolic syndrome are associated with abnormal postprandial lipoprotein metabolism, with a significant delay in the clearance of many lipid parameters, including triglycerides and chylomicrons." | ( Arca, M, 2015) |
| "The metabolic syndrome is a cluster of risk factor for diabetes and cardiovascular diseases." | ( Albiero, M; Avogaro, A; Fadini, GP, 2015) |
| "Metabolic syndrome is a complex disorder characterized by the presence of insulin resistance (IR), type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT), or impaired fasting glucose (IFG), plus at least two of the following conditions--hypertension, hyperlipidemia, obesity, and microalbuminuria." | ( Bacchetti, T; Emanuelli, M; Ferretti, G; Giuliante, R; Klöting, I; Polidori, C; Rocchetti, R; Sartini, D, 2015) |
| "The prevalence of metabolic syndrome is high in premenopausal young adult SLE patients." | ( Bonfá, E; Borba, EF; Muniz, LF; Pereira, RMR; Silva, TF, 2015) |
| "Metabolic syndrome is a major risk factor for the development of diabetes mellitus and cardiovascular diseases." | ( Adler, GK; Alvarez de la Rosa, D; El Mogrhabi, S; Fallo, F; Feraco, A; Jaisser, F; Nguyen Dinh Cat, A; Quilliot, D; Rossignol, P; Sierra-Ramos, C; Touyz, RM; Urbanet, R; Venteclef, N, 2015) |
| "Metabolic syndrome is a disorder described by reduced insulin sensitivity, overweight, hyperlipidaemia, high blood pressure and myocardial disorders, mainly due to high fat diet and lack of physical activity." | ( Beniwal, M; Grewal, AS; Lather, V; Pandita, D; Sekhon, BS, 2016) |
| "The metabolic syndrome is a common problem world-wide and includes abdominal obesity, hypertension, dyslipidemia, and hyperglycemia disorders." | ( Hosseini, A; Hosseinzadeh, H, 2015) |
| "Metabolic syndrome is characterized with abdominal obesity, insulin resistance, dyslipidemia and hepatic dysfunction." | ( Chauhan, Y; Goyal, R; Khah, S; Sharma, PL, 2015) |
| "Metabolic syndrome is a cluster of metabolic abnormalities characterized by obesity, insulin resistance, hypertension and dyslipidemia." | ( Greenwald, SE; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Pannangpetch, P; Prachaney, P; Sangartit, W; Senaphan, K, 2015) |
| "Metabolic syndrome is characterized by a cluster of atherosclerotic cardiovascular risk factors." | ( Kang, SG; Lee, YA; Nam, SH; Rho, JS; Song, SW, 2015) |
| "Metabolic syndrome is a cluster of conditions that synergistically increase the risk of cardiovascular disease, type 2 diabetes, and premature mortality." | ( Mayans, L, 2015) |
| "The prevalence of metabolic syndrome is especially high in older adults." | ( Christou, DD; English, M; Hwang, MH; Luttrell, M; Meade, TH; Yoo, JK, 2015) |
| "Obesity as part of metabolic syndrome is a major lifestyle disorder throughout the world." | ( Brown, L; Panchal, SK; Poudyal, H, 2015) |
| "Metabolic syndrome is a growing worldwide health problem." | ( Cáceres, P; Decap, V; Hernández-Salinas, R; Iturriaga, R; Leguina, A; Perez, D; Urquiaga, I; Velarde, V, 2015) |
| "Metabolic syndrome is characterized by visceral adiposity, insulin resistance, high triglyceride (TG)- and low high-density lipoprotein cholesterol-levels, hypertension, and diabetes-all of which often cause cardiovascular and cerebrovascular diseases." | ( Kurabayashi, M; Nakamura, T; Okajima, F; Sato, K; Tomono, S; Uchiyama, T, 2015) |
| "Metabolic syndrome is likely influenced by a complex interaction between exposure to secondhand smoke (SHS) and diet, but no studies have evaluated this relationship." | ( Bachand, A; Clark, ML; Moore, BF; Nelson, TL; Peel, JL; Reynolds, SJ, 2016) |
| "Metabolic syndrome is characterized by low-grade chronic systemic inflammation, which is associated with intestinal hyperpermeability." | ( Murakami, Y; Suzuki, T; Tanabe, S, 2016) |
| "The metabolic syndrome is a pathology of phylogenetically earlier insulin-independent visceral fatty acids." | ( Titov, VN, 2015) |
| "The metabolic syndrome is a multiplex risk factor for atherosclerotic cardiovascular disease and type 2 diabetes." | ( Grundy, SM, 2016) |
| "Metabolic syndrome is associated with pathological remodeling of the heart and adjacent vessels." | ( Bardia, A; Huang, T; Khabbaz, KR; Lassaletta, AD; Liu, D; Mahmood, F; Matyal, R; Owais, K; Saraf, R; Sellke, F; Senthilnathan, V, 2016) |
| "Metabolic syndrome is associated with several disorders, including hypertension, diabetes, hyperlipidemia as well as cardiovascular diseases and stroke." | ( Akaberi, M; Hosseinzadeh, H, 2016) |
| "Metabolic syndrome is a progressive condition that encompasses a wide array of disorders with specific metabolic abnormalities presenting at different times." | ( Feyh, A; Shapiro, JI; Sodhi, K; Srikanthan, K; Visweshwar, H, 2016) |
| "Obesity and metabolic syndrome are the common causes of reproductive and fertility disorders in women." | ( Barros, Pde T; Benevides, RO; Fontelles, JL; França, LM; Gaspar, RS; Paes, AM; Vale, CC, 2016) |
| "Metabolic syndrome is a global public health problem, and regular physical activity is a well-known critical factor in its management." | ( Choi, YH; Kim, J, 2016) |
| "Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality." | ( Catalano, A; Matacchione, G; Micucci, C; Valli, D, 2016) |
| "Metabolic syndrome is not associated with PC (39." | ( Calatrava, A; de Gracia, A; Fuentes-Pastor, J; Gomez-Ferrer, A; Marrugo, C; Ortiz, I; Pellejero, P; Ramírez-Backhaus, M; Rodriguez-Torreblanca, C; Rubio-Briones, J; Solsona-Narbón, E, 2016) |
| "Metabolic syndrome is a complex of disorders that includes visceral obesity, insulin resistance, hypertension, and dyslipidemia." | ( Iwata, S; Kagota, S; Maruyama, K; Shinozuka, K; Wakuda, H, 2016) |
| "The components of metabolic syndrome are all suggested as independent cardiovascular disease risk factors along with high mortality and morbidity rates accompanied by many organ and system complications." | ( Ercan, H; Kiyici, A; Marakoglu, K; Oncel, M, 2016) |
| "Metabolic syndrome is defined by a constellation of complex coexisting cardiometabolic risk factors such as hyperglycemia, dyslipidemia, inflammation, abdominal obesity, coagulopathies, and hypertension that raise the risk of diabetes mellitus and cardiovascular disease." | ( Hassani, FV; Hosseinzadeh, H; Shirani, K, 2016) |
| "Metabolic syndrome is a serious health problem in the present world." | ( Chakraborti, AS; Sil, R, 2016) |
| "Patients with metabolic syndrome are at risk for poor functional outcome and failure of treatment after corticosteroid injection for carpal tunnel syndrome." | ( Baek, GH; Baek, JR; Gong, HS; Lee, BK; Noh, JH; Park, MH; Roh, YH, 2016) |
| "The metabolic syndrome is an important disease around the world, consisting in a combination of characteristics including abdominal obesity, dyslipidemia, hypertension, and insulin resistance." | ( Camacho-Arroyo, I; Coyoy, A; Guerra-Araiza, C, 2016) |
| "Metabolic syndrome is independently associated with an increased 20-year all-cause mortality risk among patients with stable CAD." | ( Fisman, EZ; Goldenberg, I; Klempfner, R; Peled, Y; Shlomo, N; Tenenbaum, A; Tzur, B; Younis, A, 2016) |
| "Metabolic syndrome is associated with other medical conditions like cardiovascular diseases, psychiatric disorders, erectile dysfunction, polycystic ovarian syndrome and colorectal cancer." | ( Cheah, WK; Lim, KG, 2016) |
| "The metabolic syndrome is associated with prolonged stress and hyperactivity of the sympathetic nervous system and afflicted subjects are prone to develop cardiovascular disease." | ( Andersson, DC; Fauconnier, J; Jardemark, K; Katz, A; Lanner, JT; Llano-Diez, M; Sinclair, J; Westerblad, H; Yamada, T; Zhang, SJ; Zong, M, 2016) |
| "Metabolic syndrome is a clustering of interrelated risk factors for cardiovascular disease and diabetes." | ( Andreadou, I; Brown, L; Efentakis, P; Gikas, E; Halabalaki, M; Lemonakis, N; Poudyal, H; Skaltsounis, L, 2017) |
| "Metabolic syndrome is often associated with disruption of circadian rhythm of systemic haemodynamics and cardiovascular disease." | ( Fujisawa, Y; Hitomi, H; Nakano, D; Nishiyama, A; Rahman, A, 2017) |
| "The metabolic syndrome is a socially important disorder of energy utilization and storage, recognized as a factor predisposing to the development of depression, anxiety and cognitive impairment in humans." | ( Gancheva, SM; Zhelyazkova-Savova, MD, 2016) |
| "Metabolic syndrome is highly prevalent in young adult female dermatomyositis patients and is related to age and disease activity." | ( Borba, EF; Mello, SB; Shinjo, SK; Silva, MG, 2016) |
| "Metabolic syndrome is a constellation of risk factors with increased predilection towards occurrence of cardiovascular diseases." | ( Chandrasekaran, I; Dkhar, SA; George, M; Gunaseelan, V; Kamalanathan, S; Paul, AA; Selvarajan, S; Thabah, MM, 2017) |
| "Metabolic syndrome is characterized by a pronounced sympathetic overactivity as documented by the marked increase in muscle sympathetic nerve traffic (MSNA) as well as in plasma norepinephrine values reported in this condition." | ( Dell'Oro, R; Grassi, G; Macchiarulo, M; Mancia, G; Quarti Trevano, F; Seravalle, G; Valena, C; Villa, P, 2017) |
| "Metabolic syndrome is one of the most important health issues worldwide." | ( Baba, H; Morimoto, Y; Ogawa, H; Takahashi, T; Tsunematsu, T; Tsuneyama, K; Uehara, H; Watanabe, S, 2017) |
| "Metabolic syndrome is a constellation of medical conditions that arise from insulin resistance and abnormal adipose deposition and function." | ( Baek, GH; Gong, HS; Noh, JH; Roh, YH, 2017) |
| "Metabolic syndrome is associated with overactive bladder syndrome (OAB) and increased circulating levels of succinate, an intermediate of the Krebs cycle." | ( Cammisotto, PG; Campeau, L; Mossa, AH; Velasquez Flores, M, 2017) |
| "Metabolic syndrome is a frequent condition with multifactorial aetiology." | ( Chylíková, B; Kazdová, L; Křen, V; Křenová, D; Krupková, M; Liška, F; Šeda, O; Šedová, L, 2017) |
| "Metabolic syndrome is highly prevalent among patients with type II diabetes and is reported as a strong risk factor for cardiovascular diseases as well as carpal tunnel syndrome (CTS)." | ( Bahrampour, A; Ebrahimi, H; Foroozanfar, Z; Khanjani, N; Najafipour, H, 2017) |
| "Metabolic syndrome is thought to be the main driving force for the global epidemic of cardiovascular diseases, as well as for type 2 diabetes." | ( Arlappa, N; Bhattacharya, A; Deshmukh, PR; Panja, TK; Sinha, N; Yasmin, S, 2016) |
| "Metabolic syndrome is linked to the consumption of fructose-rich diets." | ( Chivandi, E; Erlwanger, KH; Ibrahim, KG; Mojiminiyi, FBO, 2017) |
| "Metabolic syndrome is coexistence of abdominal obesity, hyperglycemia, hyperlipidemia and hypertension that causes cardiovascular diseases, diabetes and their complications, low quality and short lifespan." | ( Hosseinzadeh, H; Razavi, BM; Tousian Shandiz, H, 2017) |
| "Metabolic syndrome is an independent risk factor for psoriasis (Pso) development and is associated with more severe forms of Pso." | ( Fassio, A; Gatti, D; Giollo, A; Girolomoni, G; Gisondi, P; Idolazzi, L; Rossini, M; Viapiana, O; Zamboni, M, 2017) |
| "Metabolic syndrome is a cluster of several clinical conditions characterized by insulin-resistance and high cardiovascular risk." | ( Abraldes, JG; Kok, B; La Mura, V; Liguori, E; Pasarín, M, 2017) |
| "Metabolic syndrome is a combination of symptoms including obesity, dyslipidaemia, glucose intolerance and hypertension." | ( Ayme-Dietrich, E; Birling, MC; Bouabout, G; Champy, MF; Fertak, LE; Herault, Y; Jacob, H; Madeira, L; Monassier, L; Mudgett, J; Pavlovic, G; Petit-Demoulière, B; Sorg, T, 2018) |
| "Posttransplant metabolic syndrome is a common occurrence that increases the risk of steatosis in the graft liver." | ( Carter, D; Chang, C; Dieterich, DT, 2018) |
| "Metabolic syndrome is a major risk factor for the development of cardiovascular diseases and diabetes, among other conditions." | ( Arbo, BD; Bassuino, DM; Cecconello, AL; Driemeier, D; Niches, G; Ribeiro, MF; Zanini, P, 2018) |
| "Obesity and metabolic syndrome are preventable complex-multifactorial disorders that severely increase risk of cardiovascular disease (CVD)." | ( Lalwani, P; Lima, ES; Mallmann, NH, 2018) |
| "Metabolic syndrome is a multi-causal disease." | ( Alves, MA; Bricarello, LP; Fernandes, R; Retondario, A; Rockenbach, G; Trindade, EBSM; Vasconcelos, FAG, 2019) |
| "Metabolic syndrome is present in a significant proportion of Egyptian patients with adult SLE." | ( Hammam, N; Mohamed, AAA; Rashad, SM, 2018) |
| "Metabolic syndrome is the cluster of risk factors that leads to increased episodes of cardiovascular disease (CVD)." | ( Chan, K; Koon, CM; Lau, CBS; Lau, KM; Law, HW; Leung, PC; Wang, Y; Wat, E; Yan, C, 2018) |
| "This metabolic syndrome is characterized by a combination of physiological, metabolic, and molecular alterations such as insulin resistance, dyslipidemia, and central obesity." | ( Actis Dato, V; Chiabrando, GA, 2018) |
| "The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes." | ( Blöcher, R; Hartmann, M; Hye Khan, MA; Imig, JD; Kolb, L; Proschak, E; Skibba, M, 2018) |
| "Metabolic syndrome is a serious health problem worldwide." | ( Cheng, Q; Ji, B; Sanidad, KZ; Wang, C; Yang, M; Zhang, J; Zhao, L; Zhou, F, 2018) |
| "Metabolic syndrome is a complex disease that is exponentially increasing in the western world, and diet is one of the possible ways to improve the metabolic status of patients." | ( Avguštin, G; Lipoglavšek, L; Orel, R; Velikonja, A; Zorec, M, 2019) |
| "Metabolic syndrome is a combination of dysregulated cardiometabolic risk factors characterized by dyslipidemia, impaired glucose tolerance, insulin resistance, inflammation, obesity as well as hypertension." | ( Bishayee, A; Deshmukh, RR; Kumar, P; Kumar, S; Sharma, H, 2018) |
| "Metabolic syndrome is characterized by a combination of several metabolic disorders, including obesity, hyperglycemia, and hyperlipidemia." | ( An, J; Choi, HR; Kim, J; Kim, K; Kong, H; Kwon, JW; Lee, H; Lee, SJ; Lee, TB; Song, Y, 2018) |
| "Metabolic syndrome is known to increase the risk of developing a number of life threatening diseases including coronary heart disease, hypertension, and type 2 diabetes." | ( Chen, H; Chen, J; Feng, J; Huang, XF; Jones, A; Li, J; Li, R; Tan, Y; Wang, S; Wilson, I; Yang, F; Zhang, L, 2018) |
| "Metabolic syndrome is an agglomeration of disorders including obesity, diabetes and cardiovascular diseases and characterized as chronic mild inflammation which elevates the circulatory inflammatory markers." | ( Jha, D; Mitra Mazumder, P, 2019) |
| "Thyroid disease and metabolic syndrome are both associated with cardiovascular disease." | ( Jeon, YK; Kim, BH; Kim, EH; Kim, IJ; Kim, JH; Kim, JM; Kim, M; Kim, SS; Kim, YK; Lee, H, 2019) |
| "Metabolic syndrome is associated with increases in both inflammation and aspirin resistance, but effectiveness of aspirin in improving reproductive health among women with metabolic syndrome is unknown." | ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| "Metabolic syndrome is a widely distributed condition progressing to cardiovascular disease." | ( Gasparova, Z; Knezl, V; Liptak, B, 2019) |
| "The metabolic syndrome is highly prevalent in patients with schizophrenia." | ( Kelly, CW; McEvoy, JP; Miller, BJ, 2019) |
| "Metabolic syndrome is a leading global public health concern." | ( Kim, JH; Shin, WY, 2019) |
| "Metabolic syndrome is a complex disorder that comprises several other complex disorders, including obesity, hypertension, dyslipidemia, and diabetes." | ( Kwitek, AE, 2019) |
| "Metabolic syndrome is a non-communicable disease inclusive of risk factors such as central obesity, hypertension, hyperglycaemia and dyslipidaemia." | ( Abd Muid, S; Mamikutty, N; Reshidan, NH, 2019) |
| "Metabolic syndrome is a chronic-metabolic disease caused by a variety of factors, including high peripheral blood insulin levels and insulin resistance." | ( Chen, L; He, Q; Liu, X; Qing, L; Sha, S; Sun, L; Zhao, R, 2019) |
| "Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes." | ( Bora, P; Domenici, E; Leonardelli, L; Lorenzini, F; Mione, MC; Misselbeck, K; Morine, MJ; Parolo, S; Priami, C; Savoca, V, 2019) |
| "Metabolic syndrome is a multifaceted condition associated with a greater risk of various disorders (e." | ( Castillo-Henkel, EF; Flores-Herrera, H; López-Canales, JS; López-Canales, OA; López-Mayorga, RM; Lozano-Cuenca, J; Valencia-Hernández, I, 2020) |
| "Metabolic syndrome is a complex of metabolic disorders characterized by oxidative stress which compromises cell functions and entails multiple organs pathologies." | ( Abdoon, IH; Khalid, H; Osman, B; Saad, AM; Suliman, HM, 2020) |
| "Metabolic syndrome is defined by hyperlipidemia and cardiovascular complications." | ( Bandaru, VVR; Bedja, D; Campbell, SA; Chatterjee, S; Iocco, D; Kim, G; Ma, S; Rangecroft, AB; Zheng, L, 2020) |
| "Metabolic syndrome is a disorder characterized by dyslipidemia, insulin resistance, abdominal fat, high blood pressure, hypertriglyceridemia, and diminished high density lipoprotein cholesterol." | ( Esmaeilzadeh, D; Hosseinzadeh, H; Razavi, BM, 2020) |
| "Obesity and metabolic syndrome are well-known to be associated with multiple chronic diseases." | ( Chou, CA; Chuang, SF, 2020) |
| "Metabolic syndrome is characterized by the coexistence of different metabolic disorders which increase the risk of developing type 2 diabetes mellitus and cardiovascular diseases." | ( De Martin, S; Gabbia, D, 2020) |
| "The rates of metabolic syndrome are increasing in parallel with the increasing prevalence of obesity, primarily due to its concomitant insulin resistance." | ( Cano, A; Cortés-Sierra, L; García-Pérez, MÁ; Hidalgo-Mora, JJ; Tarín, JJ, 2020) |
| "Metabolic syndrome is a predictor of cardiovascular disease and type 2 diabetes mellitus and is defined as the accumulation of multiple risk factors caused by abdominal visceral obesity." | ( Fukuhara, I; Hatakeyama, Y; Kanahori, S; Kishimoto, Y; Kitagawa, M; Nakagawa, S; Suzuki, T; Tomita, S, 2020) |
| "Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular diseases, and comprises obesity, hypertension, impaired glucose metabolism and dyslipidaemia." | ( Stowasser, M; Thuzar, M, 2021) |
| "Metabolic syndrome is known as a group of metabolic abnormalities with features including central obesity, insulin resistance, hypercholesterolemia, hypertriglyceridemia, and hypertension as well as low level of high-density lipoprotein (HDL)-cholesterol." | ( Askari, VR; Baradaran Rahimi, V; Hosseinzadeh, H, 2021) |
| "The presence of metabolic syndrome is associated with increased incidence rates of low-grade albuminuria and CKD the middle-aged and elderly Chinese populations." | ( Feng, Q; Feng, W; Huang, C; Li, F; Lin, D; Qi, Y; Ren, M; Sun, K; Yan, L; Yang, C; You, L, 2021) |
| "Metabolic syndrome is linked to an increased risk of cardiovascular complications by a mechanism involving mainly decreased nitric oxide (NO) bioavailability and impaired NO-soluble guanylate cyclase (sGC)- cyclic guanosine monophosphate (cGMP) signalling (NO-sGC-cGMP)." | ( Desfontis, JC; Doghri, Y; Dubreil, L; Fleurisson, R; Hélissen, O; Lalanne, V; Mallem, MY; Thorin, C, 2021) |
| "Metabolic syndrome is a condition whose incidence has been increasing around the world." | ( Alejandra Castillo-Martinez, N; Alejandra Chavez-Santoscoy, R; Alejandra Ramírez-Rodríguez, A; Hidalgo-Ledesma, M; Leyva-Soto, A; Porras, O; Serrano-Medina, A, 2021) |
| "Metabolic syndrome is characterized by an array of comorbidities." | ( Alves, JV; Barbosa, NC; Carvalho, KFDS; Costa, RMD; Ferreira, AAM, 2021) |
| "The metabolic syndrome is a cluster of conditions that increase an individual's risk of developing diseases." | ( Anand, ATS; Hui, ST; Lang, JM; Lin, AJ; Moore, TM; Nguyen, CQ; Norheim, F; Stiles, L; Strumwasser, AR; Terrazas, A; Turcotte, LP; Zhou, Z; Zhu, X, 2021) |
| "Metabolic syndrome is a pathological condition characterized by diabetes with insulin resistance, abdominal obesity, dyslipidemia, and hypertension." | ( Emami, SA; Jafari, F; Jafari, M; Jamialahmadi, T; Moghadam, AT; Mohammadpour, AH; Sahebkar, A, 2021) |
| "Metabolic syndrome is a prevalent disease resulting from an interplay of genomic component and the exposome." | ( Šeda, O, 2021) |
| "Metabolic syndrome is a constellation of risk factors, including obesity, hypertension, insulin resistance, and altered lipid profile, which, if left untreated, will often progress to type 2 diabetes, which frequently complicates the syndrome [." | ( Barbagallo, M; Dominguez, LJ; Veronese, N, 2022) |
| "In our study Metabolic syndrome is observed in 12." | ( Dubey, A; Gourh, V, 2022) |
| "Metabolic syndrome is a constellation of interrelated risk factors that increase the risk of cardiovascular diseases (CVD) and diabetes mellitus." | ( Ingawale, S; Raghorte, N; Rajadhyaksha, A; Sarate, N, 2022) |
| "Metabolic syndrome is a disease the World Health Organization has called a new pandemic of the 21st century." | ( Lozhkina, NG; Spiridonov, AN, 2022) |
| "Metabolic syndrome is one such risk factor for PD." | ( Shah, J; Soni, R, 2022) |
| "The metabolic syndrome is currently becoming more common." | ( Averyanova, IV, 2022) |
| "Metabolic syndrome is a cluster of risk factors for cardiovascular disease afflicting more than 1 billion people worldwide and is increasingly being identified in younger age groups and in socioeconomically disadvantaged settings in the global south." | ( Chen, YT; Colston, JM; François, R; Guerrant, RL; Hinson, P; Kosek, MN; Nguyen, NH; Olortegui, MP; Peñataro Yori, P; Rengifo Trigoso, D; Siguas Salas, M, 2022) |
| "Metabolic Syndrome is a clustering of obesity, hyperglycemia/insulin resistance, dyslipidemia, and hypertension." | ( Mittleman, MA; Rangsin, R; Sakboonyarat, B, 2022) |
| "Obesity and metabolic syndrome are highly prevalent among the US population and are associated with the dysregulation of sex hormones." | ( Clegg, D; Coltharp, M; Dubey, P; Dwivedi, AK; Reddy, SY; Shi, T; Singh, V, 2022) |
| "Metabolic syndrome is an inflammatory disorder characterized by diabetes, obesity, atherosclerosis, and hypertension." | ( Alipour, A; Askari, VR; Baradaran Rahimi, V, 2022) |
| "Metabolic syndrome is diagnosed mainly in people of economically developed parts of the world and it affects 20-25% of the adult population worldwide." | ( Soukop, J; Večeřa, R, 2022) |
| "(1) Metabolic syndrome is a set of factors that considerably increase the risk of developing atherosclerosis, type 2 diabetes, and their cardiovascular complications." | ( Bosiacki, M; Chlubek, D; Cybulska, AM; Grochans, E; Panczyk, M; Schneider-Matyka, D, 2022) |
| "Metabolic syndrome is a leading medical concern that affects one billion people worldwide." | ( Abosalha, A; Ahmad, W; Anwar, MA; Ashfaq, I; Boyajian, JL; Hayat, A; Islam, P; Nasir, A; Prakash, S; Rehman, MU; Schaly, S; Thareja, R, 2022) |
| "Metabolic syndromes are a group of metabolic disorders for which the molecular mechanisms are still unclear." | ( Cao, M; Chen, D; Chen, Q; Diao, N; Geng, H; Guo, C; Liu, Z; Wang, W; Zhang, D, 2023) |
| "Background Metabolic syndrome is characterized by insulin resistance, which impairs intracellular signaling pathways and endothelial NO bioactivity, leading to cardiovascular complications." | ( Adachi, T; Endo, S; Ido, Y; Ishinoda, Y; Kagami, K; Kimura, T; Nagatomo, Y; Namba, T; Osaki, A; Sato, A; Satoh, Y; Toya, T; Yumita, Y, 2022) |
| "Background Metabolic syndrome is characterized by insulin resistance, which impairs intracellular signaling pathways and endothelial NO bioactivity, leading to cardiovascular complications." | ( Adachi, T; Endo, S; Ido, Y; Ishinoda, Y; Kagami, K; Kimura, T; Nagatomo, Y; Namba, T; Osaki, A; Sato, A; Satoh, Y; Toya, T; Yumita, Y, 2022) |
| "Background Metabolic syndrome is characterized by insulin resistance, which impairs intracellular signaling pathways and endothelial NO bioactivity, leading to cardiovascular complications." | ( Adachi, T; Endo, S; Ido, Y; Ishinoda, Y; Kagami, K; Kimura, T; Nagatomo, Y; Namba, T; Osaki, A; Sato, A; Satoh, Y; Toya, T; Yumita, Y, 2022) |
| "Metabolic syndrome is a major risk factor for type-2 diabetes and cardiovascular disease." | ( Szallasi, A, 2022) |
| "Metabolic syndrome is a group of metabolic risk factors which are associated with an increased risk of cardiovascular disease and type2 diabetes." | ( Beyene Kassaw, A; Derbew Molla, M; Hunie Tesfa, K; Tezera Endale, H, 2022) |
| "Metabolic syndrome is characterized by multiple metabolic disorders." | ( Ghavidel, F; Hosseini, H; Majeed, M; Panahi, G; Sahebkar, A, 2023) |
| "Metabolic syndrome is a risk factor for several diseases." | ( Chiogna, LM; da Costa, CM; da Silva Schmitt, C; de Albuquerque Santos, ZE; Neto, BS; Rhoden, EL; Souto, JCS, 2023) |
| "The metabolic syndrome is associated with abdominal obesity and inflammation and is predictive of long-term risk of developing type 2 diabetes and cardiovascular disease in otherwise healthy individuals living with obesity." | ( Antoniades, C; Blond, MB; Bogh, AF; Gliemann, L; Holst, JJ; Janus, C; Jensen, JB; Jensen, SBK; Juhl, CR; Lundgren, JR; Madsbad, S; Rosenkilde, M; Sandsdal, RM; Stallknecht, BM; Torekov, SS, 2023) |
| "Metabolic syndrome is a common condition among middle-aged and elderly people." | ( Gui, J; Guo, LL; Hua, Y; Lei, Y; Li, J; Li, X; Li, Y; Liu, H; Liu, M; Sun, L; Wang, C; Wei, H; Yang, L; Yuan, T; Zhang, D; Zhang, L, 2023) |
| "Metabolic syndrome is manifested by visceral obesity, hypertension, glucose intolerance, hyperinsulinism, and dyslipidemia." | ( Barone, S; Luo, H; Soleimani, M; Zahedi, K, 2023) |
| "The metabolic syndrome is a cluster of overlapping conditions resulting in an increased incidence of type 2 diabetes, cardiovascular disease, and cancer." | ( Janssen, JAMJL, 2023) |
| "Obesity with metabolic syndrome is highly prevalent and shortens lifespan." | ( Chaves, IZ; Hansen, KE; Murali, S; Ney, DM; Suen, G, 2023) |
| "Metabolic syndrome is continuously increasing among the world's populations." | ( Al-Asmari, F; Buranasompob, A; Dahal, M; Dhakal, M; Koirala, P; Maqsood, S; Nirmal, NP; Rai, S, 2023) |
| "Metabolic syndrome is high in patients with type 2 diabetes mellitus." | ( Khatiwada, S; Poudyal, S; Sharma, K; Subba, HK, 2023) |
| "Metabolic syndrome is a collection of abnormalities, including at least three of the following insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease." | ( Anaya, BJ; Ballesteros, MP; Cerda, JR; D'Atri, RM; Kara, A; Luciano, FC; Ruiz, HK; Serrano, DR; Yuste, I, 2023) |
| "Components of the metabolic syndrome are more common in patients with Turner syndrome (TS) than in the general population." | ( Barański, K; Błaszczyk, E; Gawlik, AM; Gieburowska, J; Shulhai, AM, 2023) |
| "(1) Background: Metabolic syndrome is a strong predictor of cardiovascular disease thus the objective of the study was to verify the prevalence of metabolic syndrome in farmers, as well as to verify the association with sociodemographic, work and lifestyle factors." | ( Cattafesta, M; Cremonini, ACP; do Prado, CB; Ferreira, JRS; Martins, CA; Petarli, GB; Salaroli, LB, 2023) |
| "Metabolic syndrome is on the rise in India and is primarily linked to obesogenic dietary habits." | ( Kirti, K; Singh, SK, 2023) |
| "The incidence of metabolic syndrome is significantly higher in patients with irritable bowel syndrome (IBS), but the mechanisms involved remain unclear." | ( Bian, ZX; Gong, M; Huang, C; Jia, W; Lam, YY; Lau, JY; Lau, LT; Lin, C; Lu, A; Luo, J; Ning, Z; Wong, HLX; Wu, G; Xiao, H; Yang, C; Zhai, L; Zhang, C; Zhang, L; Zhang, Y; Zhao, L, 2023) |
| "Metabolic syndrome is a multifactorial disease with high prevalence worldwide." | ( Aparicio-Cadena, AR; Cabrera-Aguilar, A; Cancino-Bello, A; Chagoya-de Sánchez, V; Chávez, E; Domínguez-López, M; Lozano-Rosas, MG; Torres, N; Tovar, AR; Velasco-Loyden, G, 2023) |
| "Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular disease, i." | ( Arrebola, JP; Barrios-Rodríguez, R; Leno-Duran, E; Ortega-Rico, C; Perez-Diaz, C; Requena, P; Salcedo-Bellido, I; Uriz-Martínez, M, 2024) |